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It is demonstrated that newborn rat retinal photoreceptor cells can differentiate in monolayer culture, and synthesize 
de novo photoreceptor-specific proteins such as opsin. When maintained in serum supplemented medium on a laminin 
substrate, these cells survive for up to 3 weeks. The addition of acidic fibroblast growth factor stimulates an increase 
in the levels of opsin of 5-IO-fold control values, and prolongs cell survival by up to 6 days. 
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1. INTRODUCTION 
In recent years it has become apparent that 
growth factors other than nerve growth factor 
have profound effects on neural cells. The 
fibroblast growth factors (FGFs), both acidic 
(aFGF) and basic (bFGF), formerly termed EDGF 
II and I respectively [ 11, exert a variety of in- 
fluences on many neural primary cultures and cell 
lines. They stimulate proliferation, neurite 
outgrowth and cell survival in brain and PC-12 
cells [2-51. However, detailed molecular analysis 
of FGF effects is made difficult by lack of specific 
probes and appropriate models. 
In the present study we demonstrate the ver- 
satility of the retina as a model permitting 
molecular analysis of FGF effects on neural 
growth and differentiation. 
2. MATERIALS AND METHODS 2.4. Radioimmunoassay 
2.1. Monoclonal antibody 
Rho-4D2 has been described fully in previous reports [6,7]. 
It is specific for rod photoreceptor rhodopsin, and shows no 
RIA procedures were adapted from published methods [9]. 
Cultures were harvested by scraping at different time points 
from 3-21 days in vitro. Cells were pelleted and resuspended in 
phosphate-buffered saline (PBS), solubilized in Triton X-100 
and aliquoted into microtitre assay plates. 20-100 pg total pro- 
tein was used for each aliquot. After drying, wells were pre- 
incubated with PBS containing 1% normal goat serum (NGS) 
and 1% bovine serum albumin (BSA) for 60 min, incubated 
with rho-4D2 (1: 1000) for 60 min, washed and treated with 
Correspondence address: D. Hicks, Unite de Recherches 
Gerontologiques, INSERM Ul IS-CNRS UA630, 29, rue 
Wilhelm, 75016 Paris, France 
cross-reactivity with other retinal proteins as determined by 
radioimmunoassay (RIA), Western blotting and immunoelec- 
tron microscopy [6,7]. 
2.2. Tissue culture and biological model 
Monolayer cultures of newborn rat retinal cells were 
established and maintained as described [8]. Cells were seeded 
at lO’/cm’ onto laminin (1 pg/cm*) coated surfaces. 
aFGF was purified from bovine retina by heparin affinity 
chromatography and salt elution, purity being assessed by 
HPLC analysis [l]. It was used at 50 ng/ml [5], and was nor- 
mally added at the time of culture initiation and renewed with 
each medium change. In one series of experiments cells were 
allowed to attach and develop for 2 days prior to aFGF addi- 
tion. Semi-purified FGF (0.1 N acetic acid extract, or 0.1 N 
FGF) containing both aFGF and bFGF activities was also used, 
at a concentration producing maximal stimulation of epithelial 
cell division [l]. Heparin (Choay, France) was added at 
10 fig/ml [5]. 
2.3. Immunocytochemistry 
All antibody labelling of cells was performed as published 
previously [8]. 
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Fig. 1. Rho-4D2 labelling of retinal cells cultured in the presence or absence of FGF. Phase contrast images of cells after (a) 0 ( x 290), 
(c) 8 (x 290), (e) 11 (x 775) and (g) 15 days (x 290) in vitro without FGF, and (i) 13 (X 310) and (k) 18 days (x 310) in vitro with 
0.1 N FGF. Fluorescence images of corresponding cells (b) 0, (d) 8, (f) 11, (g) 15, (j) 13 and (1) 18 days in vitro. Note brightly labelled 
cell bodies and fibres in both tests and controls. 
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“‘I-goat anti-mouse IgG (Amersham; spec. act. 750-3000 Ci/ 
mmol) (2-5 x 10’ dpm/well) for 60 min [9]. Following 
thorough washing, individual wells were cut out and counted in 
an LKB gamma counter. 
3. RESULTS 
3.1. Immunocytochemistry 
Freshly seeded retinal cells do not express de- 
tectable opsin (fig.la,b). Opsin containing cells ap- 
pear at 2-3 days in vitro and increase in number 
and intensity of staining throughout the first 2 
weeks in culture, eventually comprising 30-40% 
of rounded neuronal-like cells (fig.lc-f). In the 
third week cells begin to retract their processes and 
remain as rounded cell bodies until they die 
(fig.lg,h). Addition of 0.1 N FGF causes a slight 
delay in the initial appearance of opsin containing 
cells, but by the second week the number (25-40’70 
of rounded cells), morphology and intensity of 
staining of labelled cells is similar in test and con- 
trol cultures (fig. li,j; table 1). FGF treated cultures 
survive for up to 6 days longer than parallel con- 
trols (fig.lk,l). 
3.2. Radioimmunoassay 
Solid phase RIA of control cultures exhibits 
either no detectable increases or slight increases in 
rho-4D2 binding with time, with a small maximum 
around lo-16 days (fig.2a-c). In cultures treated 
with 0.1 N FGF opsin levels gradually rise to attain 
maximal levels 5-lo-fold greater than controls 
around 10 days in vitro (fig.2a). Opsin levels either 
remain elevated throughout the time examined or 
decrease slightly. Similar effects are seen with 
purified aFGF (fig.2b); addition of heparin to 
cultures does not further increase rho-4D2 levels 
(fig.2b). Differences in rho-4D2 binding between 
Table 1 
Number of opsin-containing cells in the presence or absence of 
FGF 







% rounded cells labelled with rho-4D2 
Without aFGF With aFGF 
0.2 (589) 0.1 (580) 
1.6 (972) 1.1 (611) 
12.4 (894) 10.6 (692) 
28.5 (912) 24.7 (688) 
39.8 (858) 44.4 (792) 
treated and untreated cultures are usually small 
prior to 4-6 days in vitro. Addition of aFGF 2 
days after culture establishment also enhances 
rho-4D2 binding by an average of 5-lo-fold con- 
trol levels (fig.2c). 
4. DISCUSSION 
The retina is a very useful model for studies of 
the central nervous system (CNS) owing to its 
neuroectodermal origin, accessibility, precise 
organisation and the availability of specific im- 
munological markers [lo]. Monoclonal antibodies 
have been instrumental in examining various 
aspects of photoreceptor development, structure 
and function [6-lo]. In the present study we show 
that the retina is also an excellent tissue for ex- 
amining growth factor effects on the CNS. This 
value depends upon the availability of such sen- 
sitive, well characterized probes and reproducible 
tissue culture models. 
The presence of FGFs in the retina has long been 
known [l]. However, their putative role(s) in 
retinal cell biology is still poorly understood. FGFs 
exhibit angiogenic activities, and hence a role in 
retinal vascularization is postulated [ 111. However, 
their stimulatory effects on a range of neural types 
[2-51 clearly suggest they may play additional roles 
in retinal neurobiology. Also, as the presence of 
FGF in photoreceptors and the regulation of its 
binding by ATP has been demonstrated [ 11, there 
is a clear precedent for FGFs having important 
roles in photoreceptor metabolism. The present 
study demonstrates that aFGF can stimulate the 
levels of an important photoreceptor-specific pro- 
tein, opsin, and increase cell survival. bFGF has 
been reported as having no effect on retinal cell 
neurite extension or survival [4]. Although FGFs 
stimulate protein levels in glial cells [ 121 and neural 
cell lines [13], this is the first report of FGF 
stimulating specific protein levels in primary 
neurons. 
The mechanism by which FGF stimulates opsin 
levels is not presently known. As immunocyto- 
chemical labelling of test and control cultures 
reveals no obvious differences in the number, mor- 
phology or intensity of staining of photoreceptors, 
the stimulation in opsin levels does not seem to be 
due to proliferation or increased fibre outgrowth 
[2-51. It may involve an increased rate of 
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Fig.2. Radioimmunoassay of rho-4D2 binding to retinal cells cultured in the presence or absence of FGF. Values have non-specific 
binding subtracted and are expressed as mean + SE of two separate experiments. (a) Untreated (0) and 0.1 N FGF treated (0) 
cultures; (b) untreated (0), aFGF treated (A) and aFGF + heparin treated (H) cultures; (c) untreated (0) and aFGF treated (m) 
cultures, FGF added 2 days after cell seeding (arrow). 
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transcription or translation, or an increase in 
mRNA stability, which would be difficult to detect 
immunocytochemically. This possibility is being 
tested with the use of specific opsin cDNA probes. 
It is not simple differential adhesion as FGF treat- 
ment subsequent o cell attachment still elicits a 
response. Interestingly, other photoreceptor pro- 
teins show different time courses of responses cor- 
responding to their in vivo appearance (in 
preparation). The choice of substrate is also im- 
portant as FGFs may act synergistically with the 
extracellular matrix [ 141. 
In conclusion, the present study demonstrates 
that aFGF stimulates the levels of photoreceptor- 
specific proteins in vitro. It will be of great interest 
to examine FGF effects on other retinal proteins 
and to investigate its action in degenerating retina. 
The retina forms an ideal model for analyzing the 
complex effects of growth factors on the differen- 
tiation of the CNS. 
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